Back to Search

INTS

Intensity Therapeutics, Inc. Common stock
Data: 2026-02-02
$0.3714
Price
0.25%
Change
$2.5322
52W High
$0.1853
52W Low
Buy/Sell Forecast Trendline Why Moving Charts Options

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Quick Stats
Feb 02, 2026

44.8

AI Score

HOLD

0.43

Volume Ratio

Mar 12, 2026

Next Earnings

10

+ve Days (30d)

20

-ve Days (30d)

INTS Stock Summary

Last updated Feb 02, 2026

INTS is currently trading at $0.3714, positioned below its 200-day moving average of $0.41, suggesting bearish momentum. The stock has a 52-week range of $0.1853 to $2.5322.

Technical Analysis: The 50-day moving average stands at $0.42, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 41.306, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.008, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates INTS at 44.8/100 with a HOLD recommendation.

INTS (Intensity Therapeutics, Inc. Common stock) Indicators

Last updated Feb 02, 2026

Indicator Value
RSI(14) 41.306
CMF (20) -0.008
ROC (10) -10.238
ADX (14) 22.238
Indicator Value
MACD (12,26,9) -0.015
AROONOSC (14) -64.286
WILLAMS %R (14) -92.159
MFI (14) 49.525
INTS Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

INTS Price vs Max Options Open Interest
INTS Max Change In Options Open Interest

INTS Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

INTS Daily Out of Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

INTS Daily In the Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

INTS Most Active Options by Volume(near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Intensity Therapeutics, Inc. Common stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

INTS Moving Averages Analysis

INTS (Intensity Therapeutics, Inc. Common stock) Simple Moving Averages

Moving Averages are last updated Feb 02, 2026

Days MA
10 0.39
20 0.4
30 0.4
50 0.42
100 0.38
200 0.41

INTS Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 22.0 million
Earnings/Share ($) -0.54
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.3433
EPS Estimate Next Year ($) -0.22
WallStreet Target Price ($) 2.9167
Most Recent Quarter